Rising demand for cell-based therapies and technological progress in reprogramming support market expansion. Challenges ...

Choose Boston Business Journal as a preferred news source to see more of our reporting on Google. The deal could mean over ...

Eli Lilly will partner with Insilico Medicine on an artificial intelligence (AI)-based drug development collaboration that they said could generate “over $100 million” for the AI drug discovery ...

Traditional drug discovery takes 10-15 years and costs billions. Learn how AI is cutting this time to months, creating new ...

From designing proteins not found in nature to extending healthy lifespan, Retro Biosciences is applying AI models to advance cellular reprogramming for aging research. The company operates across ...

In this webinar, Jae Chang Lim and Hyun Joon Chang will discuss how a cutting-edge artificial intelligence platform is transforming early-stage drug discovery.

Insilico Medicine announced a research collaboration with Eli Lilly (LLY) that the two parties will combine Insilico’s Pharma.AI platforms with ...

Discover how DAOs revolutionize drug discovery through decentralized funding, transparency, and community governance.

Tahoe Therapeutics shares the appointments of Wayne Spevak, Ph.D. as VP of Chemistry and Ben Powell, Ph.D. as VP of Drug ...

Spinal cord injury (SCI) remains a major unmet medical challenge, often resulting in permanent paralysis and disability with ...